{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-011834","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2025-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.658175+00:00","generated_at":"2026-05-17T08:45:11.108453+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Iradimed appoints Masimo founder Joe Kiani to board; Anthony Vuoto retires","bullets":["Anthony Vuoto retired as director effective Aug 27, 2025; no disagreement with the company.","Joe Kiani, founder of Masimo and CEO of Willow Laboratories, appointed director effective Sep 2, 2025.","Kiani will serve on the Audit Committee and chair the Compensation Committee.","Board size remains at five directors after the transition.","Kiani receives standard non-employee director compensation as disclosed in the 2025 proxy."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-011834","json":"https://secwatch.observer/filing/0001558370-25-011834.json","markdown":"https://secwatch.observer/filing/0001558370-25-011834.md","text":"https://secwatch.observer/filing/0001558370-25-011834.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000155837025011834/0001558370-25-011834-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000155837025011834/irmd-20250827x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:45:11.108453+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}